Effective blood sugar control: Janumet helps lower blood sugar levels.
Dual mechanism of action: The combination of sitagliptin (a DPP-4 inhibitor) and metformin provides a dual mechanism of action, offering a comprehensive approach to managing blood sugar levels.
Increased insulin: as a DPP-4 inhibitor, Sitagliptin increases insulin production in response to elevated blood sugar levels.
Convenient: Janumet's combination therapy, with both sitagliptin and metformin in a single pill, is easy for patients to take once daily.
Potential weight benefits: Janumet is less likely to cause weight gain compared to some other diabetes medications. In certain cases, it may even contribute to modest weight loss.